Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists
References
- K. A. Fitzgerald and J. C. Kagan, Toll-like receptors and the control of immunity, Cell 180(6) (2020) 1044–1066; https://doi.org/10.1016/j.cell.2020.02.041
- C. A. Janeway and R. Medzhitov, Innate immune recognition, Annu. Rev. Immunol. 20 (2002) 197–216; https://doi.org/10.1146/annurev.immunol.20.083001.084359
- R. Medzhitov, Toll-like receptors and innate immunity, Nat. Rev. Immunol. 1 (2001) 135–145; https://doi.org/10.1038/35100529
- T. Kawai and S. Akira, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity, Immunity 34(5) (2011) 637–650; https://doi.org/10.1016/j.immuni.2011.05.006
- F. J. Barrat and R. L. Coffman, Development of TLR inhibitors for the treatment of autoimmune diseases, Immunol. Rev. 223(1) (2008) 271–283; https://doi.org/10.1111/j.1600-065X.2008.00630.x
- I. Martínez-Espinoza and A. Guerrero-Plata, The relevance of TLR8 in viral infections, Pathogens 11(2) (2022) Article ID 134; https://doi.org/10.3390/pathogens11020134
- M. J. Braunstein, J. Kucharczyk and S. Adams, Targeting Toll-like receptors for cancer therapy, Targ. Oncol. 13 (2018) 583–598; https://doi.org/10.1007/s11523-018-0589-7
- J. A. Hamerman and G. M. Barton, The path ahead for understanding Toll-like receptor-driven systemic autoimmunity, Curr. Opin. Immunol. 91 (2024) Article ID 102482; https://doi.org/10.1016/j.coi.2024.102482
- J.-Q. Chen, P. Szodoray and M. Zeher, Toll-like receptor pathways in autoimmune diseases, Clinic Rev. Allerg. Immunol. 50 (2016) 1–17; https://doi.org/10.1007/s12016-015-8473-z
- C.-Y. Lai, Y.-W. Su, K.-I. Lin, L.-C. Hsu and T.-H. Chuang, Natural modulators of endosomal Toll-like receptor-mediated psoriatic skin inflammation, J. Immunol. Res. 2017 (2017) Article ID 7807313 (15 pages); https://doi.org/10.1155/2017/7807313
- T. Celhar and A.-M. Fairhurst, Toll-like receptors in systemic lupus erythematosus: Potential for personalized treatment, Front. Pharmacol. 5 (2014) Article ID 265 (8 pages); https://doi.org/10.3389/fphar.2014.00265
- D. -Y. Oh, S. Taube, O. Hamouda, C. Kücherer, G. Poggensee, H. Jessen, J. K. Eckert, K. Neumann, A. Storek, M. Pouliot, P. Borgeat, N. Oh, E. Schreier, A. Pruss, K. Hattermann and R. R. Schumann, A functional Toll-like receptor 8 variant is associated with HIV disease restriction, J. Infecty. Dis. 198(5) (2008) 701–709; https://doi.org/10.1086/590431
- H. Z. Meås, M. Haug, M. S. Beckwith, C. Louet, L. Ryan, Z. Hu, J. Landskron, S. A. Nordbø, K. Taskén, H. Yin, J. K. Damås and T. H. Flo, Sensing of HIV-1 by TLR8 activates human T cells and reverses latency, Nat. Commun. 11 (2020) Article ID 147 (16 pages); https://doi.org/10.1038/s41467-019-13837-4
- T. Knoepfel, P. Nimsgern, S. Jacquier, M. Bourrel, E. Vangrevelinghe, R. Glatthar, D. Behnke, P. B. Alper, P.-Y. Michellys, J. Deane, T. Junt, G. Zipfel, S. Limonta, S. Hawtin, C. Andre, T. Boulay, P. Loetscher, M. Faller, J. Blank, R. Feifel and C. Betschart, Target-based identification and optimization of 5-indazol-5-yl pyridones as Toll-like receptor 7 and 8 antagonists using a biochemical TLR8 antagonist competition assay, J. Med. Chem. 63(15) (2020) 8276–8295; https://doi.org/10.1021/acs.jmedchem.0c00130
- P. B. Alper, J. Deane, C. Betschart, D. Buffet, G. Collignon Zipfel, P. Gordon, J. Hampton, S. Hawtin, M. Ibanez, T. Jiang, T. Junt, T. Knoepfel, B. Liu, J. Maginnis, U. McKeever, P.-Y. Michellys, D. Mut-nick, B. Nayak, S. Niwa, W. Richmond and X. Zhu, Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway, Bioorg. Med. Chem. Lett. 30(17) (2020) Article ID 127366; https://doi.org/10.1016/j.bmcl.2020.127366
- C. P. Mussari, D. S. Dodd, R. K. Sreekantha, L. Pasunoori, H. Wan, S. L. Posy, D. Critton, S. Ruepp, M. Subramanian, A. Watson, P. Davies, G. L. Schieven, L. M. Salter-Cid, R. Srivastava, D. M. Tagore, S. Dudhgaonkar, M. A. Poss, P. H. Carter and A. J. Dickman, Discovery of potent and orally bioavailable small molecule antagonists of Toll-like receptors 7/8/9 (TLR7/8/9), ACS Med. Chem. Lett. 11(9) (2020) 1751–1758; https://doi.org/10.1021/acsmedchemlett.0c00264
- M. Grabowski, M. Bermudez, T. Rudolf, D. Šribar, P. Varga, M. S. Murgueitio, G. Wolber, J. Rade-mann and G. Weindl, Identification and validation of a novel dual small-molecule TLR2/8 anta- gonist, Biochem. Pharmacol. 177 (2020) Article ID 113957; https://doi.org/10.1016/j.bcp.2020.113957
- A. Dolšak, D. Šribar, A. Scheffler, M. Grabowski, U. Švajger, S. Gobec, J. Holze, G. Weindl, G. Wolber and M. Sova, Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure–activity relationships, Eur. J. Med. Chem. 225 (2021) Article ID 113809; https://doi.org/10.1016/j.ejmech.2021.113809
- D. Šribar, M. Grabowski, M. S. Murgueitio, M. Bermudez, G. Weindl and G. Wolber, Identification and characterization of a novel chemotype for human TLR8 inhibitors, Eur. J. Med. Chem. 179 (2019) 744–752; https://doi.org/10.1016/j.ejmech.2019.06.084
- J. J. Naleway, Y. Jiang and R. Link-Cole, Reagents and methods for direct labeling of nucleotides; Retrieved from https://patents.google.com/patent/US20130150254A1/en?oq=US20130150254
- N. Varga, I. Sutkeviciute, C. Guzzi, J. McGeagh, I. Petit-Haertlein, S. Gugliotta, J. Weiser, J. Angulo, F. Fieschi and A. Bernardi, Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: Synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside, Chem. Eur. J. 19(15) (2013) 4786–4797; https://doi.org/10.1002/chem.201202764
- M. Grabowski, M. S. Murgueitio, M. Bermudez, J. Rademann, G. Wolber and G. Weindl, Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening, Biochem. Pharmacol. 154 (2018) 148–160; https://doi.org/10.1016/j.bcp.2018.04.018
- J. Holze, F. Lauber, S. Soler, E. Kostenis and G. Weindl, Label-free biosensor assay decodes the dynamics of Toll-like receptor signaling, Nat. Commun. 15 (2024) Article ID 9554 (18 pages); https://doi.org/10.1038/s41467-024-53770-9
- P. Labute, Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures, Proteins 75(1) (2009) 187–205; https://doi.org/10.1002/prot.22234
- G. Jones, P. Willett, R. C. Glen, A. R. Leach and R. Taylor, Development and validation of a genetic algorithm for flexible docking, J. Mol. Biol. 267(3) (1997) 727–748; https://doi.org/10.1006/jmbi.1996.0897
- O. Korb, T. Stützle and T. E. Exner, Empirical scoring functions for advanced protein-ligand docking with PLANTS, J. Chem. Inf. Model. 49(1) (2009) 84–96; https://doi.org/10.1021/ci800298z
- T. A. Halgren, Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94, J. Comput. Chem. 17(5–6) (1996) 490–519; https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
- G. Wolber and T. Langer, LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters, J. Chem. Inf. Model. 45(1) (2005) 160–169; https://doi.org/10.1021/ci049885e
- P. Mark and L. Nilsson, Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K, J. Phys. Chem. A 105(43) (2001) 9954–9960; https://doi.org/10.1021/jp003020w
- E. Harder, W. Damm, J. Maple, C. Wu, M. Reboul, J. Y. Xiang, L. Wang, D. Lupyan, M. K. Dahlgren, J. L. Knight, J. W. Kaus, D. S. Cerutti, G. Krilov, W. L. Jorgensen, R. Abel and R. A. Friesner, OPLS3: A force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput. 12(1) (2016) 281–296; https://doi.org/10.1021/acs.jctc.5b00864
- S. Nosé, A molecular dynamics method for simulations in the canonical ensemble, Mol. Phys. 52(2) (1984) 255–268; https://doi.org/10.1080/00268978400101201
- W. G. Hoover, Canonical dynamics: Equilibrium phase-space distributions, Phys. Rev. A Gen. Phys. 31 (1985) 1695–1697; https://doi.org/10.1103/physreva.31.1695
- G. J. Martyna, M. E. Tuckerman, D. J. Tobias and M. L. Klein, Explicit reversible integrators for extended systems dynamics, Mol. Phys. 87(5) (1996) 1117–1157; https://doi.org/10.1080/00268979600100761
- W. Humphrey, A. Dalke and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. 14(1) (1996) 33–38; https://doi.org/10.1016/0263-7855(96)00018-5
- A. Bock, M. Bermudez, F. Krebs, C. Matera, B. Chirinda, D. Sydow, C. Dallanoce, U. Holzgrabe, M. De Amici, M. J. Lohse, G. Wolber and K. Mohr, Ligand binding ensembles determine graded agonist efficacies at a G protein-coupled receptor, J. Biol. Chem. 291(31) (2016) 16375–16389; https://doi.org/10.1074/jbc.M116.735431
- M. Janežič, K. Valjavec, K. B. Loboda, B. Herlah, I. Ogris, M. Kozorog, M. Podobnik, S. G. Grdadolnik, G. Wolber and A. Perdih, Dynophore-based approach in virtual screening: A case of human DNA topoisomerase IIα, Int. J. Mol. Sci. 22(24) (2021) Article ID 13474; https://doi.org/10.3390/ijms222413474
- N. Fuchs, L. Calvo-Barreiro, V. Talagayev, S. Pach, G. Wolber and M. T. Gabr, From virtual screens to cellular target engagement: New small molecule ligands for the immune checkpoint LAG-3, ACS Med. Chem. Lett. 15(11) (2024) 1884–1890; https://doi.org/10.1021/acsmedchemlett.4c00350
- H. Tanji, U. Ohto, T. Shibata, K. Miyake and T. Shimizu, Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands, Science 339(6126) (2013) 1426–1429; https://doi.org/10.1126/science.1229159
- S. Zhang, Z. Hu, H. Tanji, S. Jiang, N. Das, J. Li, K. Sakaniwa, J. Jin, Y. Bian, U. Ohto, T. Shimizu and H. Yin, Small-molecule inhibition of TLR8 through stabilization of its resting state, Nat. Chem. Biol. 14 (2018) 58–64; https://doi.org/10.1038/nchembio.2518
- T. Matziol, V. Talagayev, T. Slokan, N. Strašek Benedik, J. Holze, M. Sova, G. Wolber and G. Weindl, Discovery of novel isoxazole-based small-molecule Toll-like receptor 8 antagonists, J. Med. Chem. 68(4) (2025) 4888–4907; https://doi.org/10.1021/acs.jmedchem.4c03148
- Z. Hu, H. Tanji, S. Jiang, S. Zhang, K. Koo, J. Chan, K. Sakaniwa, U. Ohto, A. Candia, T. Shimizu and H. Yin, Small-molecule TLR8 antagonists via structure-based rational design, Cell. Chem. Biol. 25(10) (2018) 1286–1291; https://doi.org/10.1016/j.chembiol.2018.07.004
Language: English
Page range: 159 - 183
Accepted on: Mar 28, 2025
Published on: Jul 3, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2025 Nika Strašek Benedik, Valerij Talagayev, Troy Matziol, Ana Dolšak, Izidor Sosič, Günther Weindl, Gerhard Wolber, Matej Sova, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.